Publicaciones científicas

  • Intraoperative Electron-Beam Radiation Therapy for Pediatric Ewing Sarcomas and Rhabdomyosarcomas: Long-Term Outcomes

    Sole CV(1), Calvo FA(2), Polo A(3), Cambeiro M(4), Gonzalez C(5), Desco M(6), Martinez-Monge R(4).

    (1) Department of Radiation Oncology, Instituto de Radiomedicina, Santiago, Chile; School of Medicine, Complutense University, Madrid, Spain.
    (2) School of Medicine, Complutense University, Madrid, Spain; Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    (3) Service of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
    (4) Service of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
    (5) School of Medicine, Complutense University, Madrid, Spain; Service of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    (6) School of Medicine, Complutense University, Madrid, Spain; Department of Experimental Surgery and Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

    International Journal of Radiation Oncology, Biology, Physics 01 de AGOSTO de 2015

  • The Clinical Utility of Basophil Activation Testing in Diagnosis and Monitoring of Allergic Disease

    Hoffmann HJ(1), Santos AF(2,3,4), Mayorga C(5), Nopp A(6), Eberlein B(7), Ferrer M(8), Rouzaire P(9), Ebo D(10), Sabato V(10), Sanz ML(8), Pecaric-Petkovic T(11), Patil SU(12), Hausmann OV(13,14), Shreffler WG(12), Korosec P(15), Knol EF(16).

    (1) Department of Respiratory Diseases and Allergy, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
    (2) Department of Paediatric Allergy, Division of Asthma, Allergy & Lung Biology, King's College London, United Kingdom.
    (3) MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
    (4) Immunoallergology Department, Coimbra University Hospital, Coimbra, Portugal.
    (5) Research Laboratory and Allergy Service, IBIMA-Regional University Hospital of Malaga UMA, Malaga, Spain.
    (6) Clinical Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    (7) Department of Dermatology and Allergy Biederstein, Technische Universität München, Munich, Germany.
    (8) Department of Allergy and Clinical Immunology, Clínica Universidad de Navarra, Pamplona, Spain.
    (9) Department of Immunology, University Hospital, Clermont-Ferrand and ERTICa Research Group, University of Auvergne, EA4677, Clermont-Ferrand, France.
    (10) Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
    (11) Adverse Drug Reactions-Analysis and Consulting (ADR-AC) GmbH, Bern, Switzerland.
    (12) Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
    (13) Department of Rheumatology, Immunology and Allergology, Inselspital, University of Bern, Bern, Switzerland.
    (14) Loewenpraxis, Luzern, Switzerland.
    (15) Laboratory for Clinical Immunology & Molecular Genetics, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
    (16) Department of Immunology and Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.

    Allergy 21 de JULIO de 2015

  • Rivaroxaban versus standard of care in venous thromboembolism prevention following hip or knee arthroplasty in daily clinical practice (Spanish data from the international study XAMOS)

    Granero J(1), Díaz de Rada P(2), Lozano LM(3), Martínez J(4), Herrera A(5); en nombre de los investigadores del grupo XAMOS España.

    (1) Departamento de Cirugía Ortopédica y Traumatología, Hospital Germans Trias i Pujol, Badalona, Barcelona, España.
    (2) Departamento de Cirugía Ortopédica y Traumatología, Clínica Universitaria de Navarra, Pamplona, España.
    (3) Departamento de Cirugía Ortopédica y Traumatología, Hospital Clínic i Provincial, Barcelona, España.
    (4) Departamento de Cirugía Ortopédica y Traumatología, Hospital de Alcorcón, Alcorcón, Madrid, España.
    (5) Departamento de Cirugía Ortopédica y Traumatología. Hospital Miguel Servet, Zaragoza, España.

    Revista Española de Cirugía Ortopédica y Traumatología 17 de JULIO de 2015

  • Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor

    Hor H(1), Francescatto L(2), Bartesaghi L(3), Ortega-Cubero S(4), Kousi M(2), Lorenzo-Betancor O(4), Jiménez-Jiménez FJ(5), Gironell A(6), Clarimón J(7), Drechsel O(8), Agúndez JA(9), Broz DK(10), Chiquet-Ehrismann R(10), Lleó A(11), Coria F(12), García-Martin E(13), Alonso-Navarro H(5), Martí MJ(14), Kulisevsky J(15), Hor CN(16), Ossowski S(8), Chrast R(3), Katsanis N(2), Pastor P(4), Estivill X(17).

    (1) Bioinformatics and Genomics Program, Centre for Genomic Regulation (CRG) Universitat Pompeu Fabra (UPF) Hospital del Mar Medical Research Institute (IMIM) CRG CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Catalonia, 08003, Spain hyun.hor@crg.cat.
    (2) Center for Human Disease Modeling, Duke University, Duke University Medical Center, Durham, NC 27710, USA.
    (3) Department of Medical Genetics, University of Lausanne, Lausanne, 1005, Switzerland Department of Neuroscience and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, 171 77, Sweden.
    4Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research (CIMA), and Department of Neurology, Clínica Universidad de Navarra, University of Navarra School of Medicine and Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Pamplona, Navarra, 31008, Spain.
    (5)Section of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, 28030, Spain.
    (6) Movement Disorders Unit, Neurology Department, Hospital de Sant Pau Sant Pau Biomedical Research Institute.
    (7) Sant Pau Biomedical Research Institute Universitat Autònoma de Barcelona and CIBERNED, Barcelona, Catalonia, 08026, Spain.
    (8) Bioinformatics and Genomics Program, Centre for Genomic Regulation (CRG) Universitat Pompeu Fabra (UPF).
    (9) Department of Pharmacology, University of Extremadura, Cáceres, 10071, Spain.
    (10) Friedrich Miescher Institute of Biomedical Research, Novartis Research Foundation and University of Basel, Faculty of Sciences and Department of Biomedicine, Basel, 4058, Switzerland.
    (11) Sant Pau Biomedical Research Institute.
    (12) Clinic for Nervous Disorders, Service of Neurology, Son Espases University Hospital, Palma de Mallorca, 07120, Spain.
    (13) Department of Biochemistry and Molecular Biology, University of Extremadura, Cáceres, 10071, Spain.
    (14) Movement Disorders Unit, Neurology Service, Hospital Clinic, CIBERNED and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, 08036, Spain.
    (15) Movement Disorders Unit, Neurology Department, Hospital de Sant Pau Universitat Autònoma de Barcelona and CIBERNED, Barcelona, Catalonia, 08026, Spain.
    (16) Bioinformatics and Genomics Program, Centre for Genomic Regulation (CRG) Universitat Pompeu Fabra (UPF) Hospital del Mar Medical Research Institute (IMIM) CRG CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Catalonia, 08003, Spain.
    (17) Bioinformatics and Genomics Program, Centre for Genomic Regulation (CRG) Universitat Pompeu Fabra (UPF) Hospital del Mar Medical Research Institute (IMIM) CRG CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Catalonia, 08003, Spain Dexeus Women's Health, University Hospital Quiron-Dexeus, Barcelona, Catalonia, 08028, Spain.

    Human Molecular Genetics 17 de JULIO de 2015

  • Differences and similarities between the competencies of a nursing supervisor and an advanced clinical nurse specialist

    Del Barrio-Linares M(1), Pumar-Méndez MJ(2).

    (1) UCI, Clínica Universidad de Navarra, Pamplona, España.
    (2) Facultad de Enfermería, Universidad de Navarra, Pamplona, España.

    Enfermería Intensiva 14 de JULIO de 2015

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de tecnología de vanguardia en la Clínica

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen nuestros profesionales de la Clínica

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica